Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_assertion description "[To determine whether vascular endothelial growth factor (VEGF) and its receptors, KDR and flt-1, may play a role in the progression of both types of sarcomas, we used mRNA in situ hybridisation (ISH) to study VEGF, KDR and flt-1 expression in selected cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_assertion evidence source_evidence_literature NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_assertion SIO_000772 11213831 NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_assertion wasDerivedFrom befree-2016 NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_assertion wasGeneratedBy ECO_0000203 NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.
- befree-2016 importedOn "2016-02-19" NP308886.RAr8WXH609dxt6-nyCp7rsXK6ED45g0wUYQILmK4sdfhY130_provenance.